Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$132,027,333
-$1,005,872 QoQ
Shares Held
5,482,863
+15.7% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#85
of 2,826 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 62%
Shared 0%
None 38%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $3,483,940,248 across 16 Drug Manufacturers - General names. PFE ranks #8 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
781,929 | $937,869,169 | |
| 2 | JNJ |
Johnson & Johnson
|
2,675,500 | $679,496,724 | |
| 3 | ABBV |
AbbVie Inc.
|
1,621,115 | $407,937,369 | |
| 4 | AZN |
Astrazeneca PLC
|
2,033,587 | $385,608,756 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,578,024 | $331,276,081 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,215,423 | $242,892,664 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,070,731 | $135,276,147 | |
| 8 | PFE |
Pfizer Inc
This page
|
5,482,863 | $132,027,333 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $132,027,333 | 5,482,863 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $133,033,205 | 4,737,650 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $129,940,269 | 5,218,485 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $109,745,843 | 4,307,137 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $96,435,294 | 3,978,354 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $89,508,094 | 3,532,285 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $100,773,403 | 3,798,470 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $107,799,877 | 3,724,944 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $78,108,572 | 2,791,586 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $76,723,196 | 2,764,800 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $84,537,022 | 2,936,333 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $125,701,526 | 3,789,615 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $121,880,849 | 3,322,815 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $146,196,269 | 3,583,242 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $148,177,674 | 2,891,836 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $128,495,765 | 2,936,375 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $150,779,710 | 2,875,829 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $227,580,658 | 4,395,995 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $271,396,570 | 4,596,047 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $211,997,448 | 4,929,027 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $219,738,818 | 5,611,308 | Shares | Defined | 2021-08-04 | |
| 2021-03-31 | $215,510,382 | 5,948,396 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $235,184,423 | 6,389,145 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $284,121,094 | 7,741,727 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $289,953,939 | 8,867,084 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $284,028,418 | 8,701,863 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||